BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4401003)

  • 1. [Inhibition of the metabolic and circulatory (cardiovascular) effects of diazoxide through alpha--and beta-receptor blockade].
    Börner E; Biro G; Kettl H; Weinges KF
    Horm Metab Res; 1969 Nov; 1(6):296-300. PubMed ID: 4401003
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of chronic adrenergic blockade on the inhibition by epinephrine of growth hormone and insulin release in sheep.
    Hertelendy F; Takahashi K; Machlin LJ; Kipnis DM
    Horm Metab Res; 1970 Sep; 2(5):257-9. PubMed ID: 4400839
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-adrenergic inhibition of immunoreactive insulin release during deep hypothermia.
    Baum D; Porte D
    Am J Physiol; 1971 Jul; 221(1):303-11. PubMed ID: 4397536
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood sugar, serum insulin and serum non-esterified fatty acid levels during thiopentone anaesthesia in dogs.
    Toso CF; Rodríguez RR; Renauld A; Sverdlik RC; Linares LM
    Can J Anaesth; 1993 Jan; 40(1):38-45. PubMed ID: 8425241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
    Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
    Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic regulation of basal serum glucose, NEFA and insulin levels.
    Gagliardino JJ; Bellone CF; Doria I; Sănchez JJ; Pereyra V
    Horm Metab Res; 1970 Nov; 2(6):318-22. PubMed ID: 4398896
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of action of diazoxide.
    Blackard WG; Aprill CN
    J Lab Clin Med; 1967 Jun; 69(6):960-7. PubMed ID: 6026525
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels, clearance rates and effects of epinephrine and norepinephrine on insulin and metabolites during alpha- and beta-adrenergic blockade in cattle in vivo, and in vitro degradation of dopamine in bovine blood.
    Fröhli D; Blum JW
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):245-53. PubMed ID: 2898856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic system and carbohydrate metabolism. Effects of beta-receptor blockade on insulin secretion and peripheral insulin sensitivity in normoglycaemic patients.
    Ferrara LA; Capaldo B; Rivellese A; Genovese S; Iovine C; Mastranzo P; Cirillo F; Mancini M
    Eur J Clin Pharmacol; 1987; 33(3):273-7. PubMed ID: 2891537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of insulin release by diazoxide and its relation to catecholamine effects in man.
    Porte D
    Ann N Y Acad Sci; 1968 Apr; 150(2):281-91. PubMed ID: 4299220
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas.
    Burr IM; Marliss EB; Stauffacher W; Renold AE
    J Clin Invest; 1971 Jul; 50(7):1444-50. PubMed ID: 5090060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism for regulation of insulin release in hypoxia.
    Baum D; Porte D
    Am J Physiol; 1972 Mar; 222(3):695-9. PubMed ID: 4401851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors.
    Burns TW; Mohs JM; Langley PE; Yawn R; Chase GR
    J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine-induced insulin and substrate changes in normal man: incomplete reversal by phentolamine.
    Meguid MM; Moore Ede MC; Fitzpatrick G; Moore FD
    J Surg Res; 1975 Apr; 18(4):365-9. PubMed ID: 1142752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.